OrthoPediatrics (NASDAQ:KIDS – Free Report) had its price target lowered by Truist Financial from $28.00 to $25.00 in a report released on Wednesday,Benzinga reports. The firm currently has a hold rating on the stock.
Other analysts have also recently issued reports about the company. Needham & Company LLC restated a “buy” rating and issued a $42.00 target price on shares of OrthoPediatrics in a report on Friday, November 8th. JMP Securities reissued a “market outperform” rating and set a $50.00 price target on shares of OrthoPediatrics in a research report on Friday, September 13th.
Read Our Latest Research Report on KIDS
OrthoPediatrics Trading Down 0.9 %
Institutional Investors Weigh In On OrthoPediatrics
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Divisadero Street Capital Management LP acquired a new stake in shares of OrthoPediatrics during the 2nd quarter worth about $514,000. Wellington Management Group LLP boosted its stake in OrthoPediatrics by 16.2% during the third quarter. Wellington Management Group LLP now owns 883,221 shares of the company’s stock worth $23,944,000 after buying an additional 122,846 shares during the period. Harbor Capital Advisors Inc. increased its position in shares of OrthoPediatrics by 268.1% during the third quarter. Harbor Capital Advisors Inc. now owns 246,860 shares of the company’s stock valued at $6,692,000 after acquiring an additional 179,803 shares during the last quarter. International Assets Investment Management LLC raised its stake in shares of OrthoPediatrics by 2,610.8% in the 3rd quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock valued at $27,000 after acquiring an additional 966 shares during the period. Finally, Sei Investments Co. lifted its holdings in shares of OrthoPediatrics by 345.2% in the 2nd quarter. Sei Investments Co. now owns 30,747 shares of the company’s stock worth $884,000 after acquiring an additional 23,841 shares during the last quarter. Hedge funds and other institutional investors own 69.05% of the company’s stock.
OrthoPediatrics Company Profile
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
See Also
- Five stocks we like better than OrthoPediatrics
- 3 Best Fintech Stocks for a Portfolio Boost
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- How Can Investors Benefit From After-Hours Trading
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.